| 1 |
Hypermanganesemia with Dystonia, Polycythemia and Cirrhosis (HMDPC) due to mutation in the SLC30A10 gene.
4
|
Mukhtiar K...Mills P
|
27117033
|
2016 |
| 2 |
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia.
4
|
Tuschl K...Wilson SW
|
27231142
|
2016 |
| 3 |
Manganese transport disorder: novel SLC30A10 mutations and early phenotypes.
4
|
Quadri M...Bonifati V
|
25778823
|
2015 |
| 4 |
SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity.
4
|
Leyva-Illades D...Mukhopadhyay S
|
25319704
|
2014 |
| 5 |
Inherited manganism: the "cock-walk" gait and typical neuroimaging features.
4
|
Avelino MA...Masruha MR
|
24746291
|
2014 |
| 6 |
Pathology of inherited manganese transporter deficiency.
4
|
Lechpammer M...Gospe SM
|
24599576
|
2014 |
| 7 |
Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder.
4
|
Stamelou M...Clayton PT
|
22926781
|
2012 |
| 8 |
Pathophysiology of manganese-associated neurotoxicity.
4
|
Racette BA...Zheng W
|
22202748
|
2012 |
| 9 |
Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.
4
|
Tuschl K...Mills PB
|
22341972
|
2012 |
| 10 |
Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.
4
|
Quadri M...Bonifati V
|
22341971
|
2012 |
| 11 |
Design of the Trial to Assess Chelation Therapy (TACT).
4
|
Lamas GA...Lee KL
|
22172430
|
2012 |
| 12 |
Manganese toxicity in a child with iron deficiency and polycythemia.
4
|
Brna P...Price V
|
21596707
|
2011 |
| 13 |
Manganese encephalopathy: an under-recognized condition in the intensive care unit.
4
|
Chalela JA...Hays A
|
21174173
|
2011 |
| 14 |
Acquired hepatocerebral degeneration.
4
|
Meissner W...Tison F
|
21496578
|
2011 |
| 15 |
Intellectual impairment in school-age children exposed to manganese from drinking water.
4
|
Bouchard MF...Mergler D
|
20855239
|
2011 |
| 16 |
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
4
|
Chakravarty K...British Association of Dermatologists (BAD)
|
16940305
|
2008 |
| 17 |
Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia--a new metabolic disorder.
4
|
Tuschl K...Clayton PT
|
18392750
|
2008 |
| 18 |
A Parkinsonian syndrome in methcathinone users and the role of manganese.
4
|
Stepens A...Donaghy M
|
18322282
|
2008 |
| 19 |
Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis.
4
|
Gospe SM...Kreutzer RA
|
11040156
|
2000 |
| 20 |
Regulation of the erythropoietin gene.
4
|
Ebert BL...Bunn HF
|
10477715
|
1999 |
| 21 |
Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease
38
|
Tuschl K...Mills PB
|
22934317
|
2012 |
